Cetera Advisor Networks’s ImmuCell ICCC Stock Holding History

Cetera Advisor Networks’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,485	Closed	-$7K	–	2043
2020 Q2	$7K	Buy	+1,485	New	+$6.47K	﹤0.01%	2859

Other funds holding ICCC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OMC

Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Cetera Advisor Networks's ICCC Position: Q3 2020 in Review

Cetera Advisor Networks sold out of ImmuCell (ICCC) in Q3 2020, closing a stake of 1,485 shares — an estimated $7K sold.

Cetera Advisor Networks first reported a position in ICCC in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 27 funds tracked by Wall St. Rank hold ICCC as of Q3 2020.

Cetera Advisor Networks reported no remaining ImmuCell position as of Q3 2020 after selling out during the quarter.
Cetera Advisor Networks sold 1,485 ImmuCell shares in Q3 2020, an estimated $7K.
Cetera Advisor Networks first reported a position in ImmuCell in Q2 2020 and held it in 1 quarter.
Cetera Advisor Networks's ImmuCell position peaked at $7K in Q2 2020.
27 funds tracked by Wall St. Rank held ImmuCell as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.